BrainStorm Cell Therapeutics
BCLI
#10103
Rank
โ‚น0.62 B
Marketcap
โ‚น95.33
Share price
14.87%
Change (1 day)
-85.89%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚น61.28 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is โ‚น61.28 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚น0.33 B-10.41%
2021-12-31โ‚น0.37 B-28.38%
2020-12-31โ‚น0.52 B212.83%
2019-12-31โ‚น0.16 B
2018-12-31N/A
2010-12-31โ‚น6.13 M-64.24%
2009-12-31โ‚น17.16 M-19.37%
2008-12-31โ‚น21.29 M-64.79%
2007-12-31โ‚น60.47 M21.27%
2006-12-31โ‚น49.87 M
2006-03-31โ‚น22.07 M
2004-03-31โ‚น1.34 M34.56%
2003-03-31โ‚น0.99 M102.04%
2002-03-31โ‚น0.49 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น2.273 T 3,709,761.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น67.12 B 109,438.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.65 B 15,662.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น564.33 B 920,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.07 B 13,076.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA